Portfolio news 0

Genomics

Greywolf Therapeutics and Genomics Launch Strategic Relationship to Develop First‑in‑Class Treatments for Autoimmune Diseases

Lumai

Lumai Launches the World’s First Optical Computing System for Real-Time, Billion-Parameter LLM Inference

First Light Fusion Ltd

Locai Labs signs contract with First Light Fusion for the supply of a domain-specific LLM for fusion energy research

Istesso Ltd

Istesso presents data showing that its first-in-class oral regenerative agent, leramistat, restores muscle quality beyond baseline in aging models

Alesi Surgical Ltd

Alesi Surgical secures £7m to tackle hazardous surgical smoke in operating theatres, led by IW Capital

First Light Fusion Ltd

First Light Fusion announces £25m successful first close of new funding round with investments from Starmaker One & UKAEA

Akamis Bio

Akamis Bio Announces Encouraging Preliminary Results from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer

Accelercomm Ltd

AccelerComm Secures 56th Patent, Strengthening Leadership in 5G Innovation for Non-Terrestrial Networks

Storm Therapeutics

STORM Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC‑15

Oxford Nanopore Technologies Plc

Cepheid and Oxford Nanopore expand partnership following successful phase one collaboration